4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow omaveloxolone: new trials by email Literature Review of omaveloxolone trials Research Report on omaveloxolone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR Omaveloxolone capsules, 2.5 mg, omaveloxolone capsules, 5 mg, omaveloxolone capsules, 10 mg - MItochondrial Myopathies | Phase 2 | Completed | Biogen | 53 | 2015-05-05 | 2025-06-05 |
| A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia Omaveloxolone Capsules, 2.5 mg, Omaveloxolone Capsules, 5 mg, Omaveloxolone Capsules, 10 mg - Friedreich Ataxia | Phase 2 | Completed | Biogen | 172 | 2015-01-31 | 2026-09-03 |
| RTA 408 Capsules in Patients With Melanoma - REVEAL Omaveloxolone Capsules (2.5 mg/capsule), Ipilimumab (3 mg/kg), Nivolumab (240 mg) - Melanoma, Unresectable (Stage III) Melanoma | Phase 1 / Phase 2 | Completed | Biogen | 41 | 2014-10-31 | 2025-06-04 |
| RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery Omaveloxolone Ophthalmic Suspension 1.0%, Omaveloxolone Opthalmic Suspension 0.5%, Placebo - Inflammation and Pain Following Ocular Surgery | Phase 2 | Completed | Biogen | 109 | 2014-02-28 | 2025-06-03 |
Endophthalmitis (1) · Eye Pain (1) · Friedreich Ataxia (1) · Inflammation (1) · Melanoma (1) · Mitochondrial Diseases (1) · Mitochondrial Myopathies (1) · Neoplasm Metastasis (1)
Biogen (4)
United States (4) · Australia (1) · Austria (1) · Denmark (1) · Italy (1) · United Kingdom (1)